Showing results (171-180 of 319) with videos related to

Sort By:
Pageof 32
Proteomics|October 4, 2002
An integrated proteome database for two-dimensional electrophoresis data analysis and laboratory information management systemSang Yun Cho, Kang-Sik Park, Jung Eun Shim, et al.
Oncotarget|April 19, 2017
Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumabChoong-Kun Lee, Seung-Seob Kim, Saemi Park, et al.
Bioorganic Chemistry|December 28, 2023
Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinomaGa-Ram Kim, Joon Hee Kang, Hyeon Joo Kim, et al.
Molecular Cancer Therapeutics|October 26, 2014
The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progressionJeong Min Kim, Hei-Cheul Jeung, Sun Young Rha, et al.
Oncology|August 11, 2011
Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profilesHyo Song Kim, Min Hee Hong, Kiyeol Kim, et al.
Cancer Chemotherapy and Pharmacology|August 10, 2014
Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxaneJi Soo Park, Hei-Cheul Jeung, Sun Young Rha, et al.
Annals of Surgical Oncology|June 22, 2010
The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-upMinkyu Jung, Hyun Joon Shin, Sun Young Rha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expressionJangsoon Lee, Soon Young Park, Eun Kyung Lee, et al.
The Oncologist|May 25, 2007
Multi-institutional phase II study of S-1 monotherapy in advanced gastric cancer with pharmacokinetic and pharmacogenomic evaluationsHei-Cheul Jeung, Sun Young Rha, Hoon Kyo Kim, et al.
Cold Spring Harbor Molecular Case Studies|September 15, 2016
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcomaKenneth S Chen, Woo Sun Kwon, Jiwoong Kim, et al.
Pageof 32